Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city

Context: From the beginning of the global HIV epidemic there has been a great concern about drug interactions (DI) considering that up to 27% of all patients may be affected by at least one type of DI, this risk increases by receiving concomitant treatments. This DI leads to negative consequences su...

Full description

Bibliographic Details
Main Authors: Patricio R. Araya, Criss V. Zambra, Yoselyn M. Castillo, Pedro P. Usedo, Francisco L. Salvador, Francisco J. González
Format: Article
Language:English
Published: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 2017-11-01
Series:Journal of Pharmacy & Pharmacognosy Research
Subjects:
Online Access:http://jppres.com/jppres/pdf/vol5/jppres16.148_5.6.327.pdf
id doaj-efc64e825dfb4707ab3b4af3e09cb0ff
record_format Article
spelling doaj-efc64e825dfb4707ab3b4af3e09cb0ff2020-11-24T21:23:52ZengAcademic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)Journal of Pharmacy & Pharmacognosy Research0719-42502017-11-0156327334Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta cityPatricio R. Araya0Criss V. Zambra1Yoselyn M. Castillo2Pedro P. Usedo3Francisco L. Salvador4Francisco J. González5Departamento de Ciencias Farmacéuticas, Facultad de Ciencias, Universidad Católica del Norte. Edificio Ñ3, Avenida Angamos 0610, Antofagasta, ChileDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias, Universidad Católica del Norte. Edificio Ñ3, Avenida Angamos 0610, Antofagasta, ChileServicio de Dermatología/UNACESS-VIH-SIDA, Hospital Regional Dr. Leonardo Guzmán. Avenida Argentina 1962, Antofagasta, Chile.Servicio de Dermatología/UNACESS-VIH-SIDA, Hospital Regional Dr. Leonardo Guzmán. Avenida Argentina 1962, Antofagasta, Chile.Servicio de Dermatología/UNACESS-VIH-SIDA, Hospital Regional Dr. Leonardo Guzmán. Avenida Argentina 1962, Antofagasta, Chile. Facultad de Medicina y Odontología, Universidad de Antofagasta, Avenida Argentina 2000, Antofagasta, Chile.Servicio de Dermatología/UNACESS-VIH-SIDA, Hospital Regional Dr. Leonardo Guzmán. Avenida Argentina 1962, Antofagasta, Chile.Context: From the beginning of the global HIV epidemic there has been a great concern about drug interactions (DI) considering that up to 27% of all patients may be affected by at least one type of DI, this risk increases by receiving concomitant treatments. This DI leads to negative consequences such as adverse drug reactions (ADR), lack of treatment adherence and new hospital admissions. Aims: To determine the prevalence of DI of antiretroviral drugs and their clinical consequences in UNACESS-VIH-SIDA patients of Hospital Regional de Antofagasta. Methods: The study included a total of 100 HIV patients. To identify DI, Micromedex database was used. All data were gathered in a pharmaceutical datasheet, the theoretical DI were identified and real DI were detected by using hematologic tests and the patient’s clinical evolution. After the detection of any real DI, a pharmaceutical intervention took place. Results: A total of 106 DI were detected; 86% of DI found were related to drug’s pharmacokinetic properties, which were mostly metabolism related interactions (96.9%); the most commonly found associations were atazanavir with ritonavir, efavirenz with atorvastatin and efavirenz with gemfibrozil. The main clinical consequences associated with DI were ADR (49%). Conclusions: High prevalence of metabolism-related interactions was found and the antiretroviral drugs mostly associated with DI were found to be atazanavir, ritonavir y efavirenz. A high prevalence of ADR was found; however, they were mild or moderate.http://jppres.com/jppres/pdf/vol5/jppres16.148_5.6.327.pdfadverse drug reactionsantiretroviral therapydrug interactions
collection DOAJ
language English
format Article
sources DOAJ
author Patricio R. Araya
Criss V. Zambra
Yoselyn M. Castillo
Pedro P. Usedo
Francisco L. Salvador
Francisco J. González
spellingShingle Patricio R. Araya
Criss V. Zambra
Yoselyn M. Castillo
Pedro P. Usedo
Francisco L. Salvador
Francisco J. González
Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
Journal of Pharmacy & Pharmacognosy Research
adverse drug reactions
antiretroviral therapy
drug interactions
author_facet Patricio R. Araya
Criss V. Zambra
Yoselyn M. Castillo
Pedro P. Usedo
Francisco L. Salvador
Francisco J. González
author_sort Patricio R. Araya
title Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
title_short Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
title_full Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
title_fullStr Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
title_full_unstemmed Drug interactions in HIV patients treated in a high complexity hospital of Antofagasta city
title_sort drug interactions in hiv patients treated in a high complexity hospital of antofagasta city
publisher Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
series Journal of Pharmacy & Pharmacognosy Research
issn 0719-4250
publishDate 2017-11-01
description Context: From the beginning of the global HIV epidemic there has been a great concern about drug interactions (DI) considering that up to 27% of all patients may be affected by at least one type of DI, this risk increases by receiving concomitant treatments. This DI leads to negative consequences such as adverse drug reactions (ADR), lack of treatment adherence and new hospital admissions. Aims: To determine the prevalence of DI of antiretroviral drugs and their clinical consequences in UNACESS-VIH-SIDA patients of Hospital Regional de Antofagasta. Methods: The study included a total of 100 HIV patients. To identify DI, Micromedex database was used. All data were gathered in a pharmaceutical datasheet, the theoretical DI were identified and real DI were detected by using hematologic tests and the patient’s clinical evolution. After the detection of any real DI, a pharmaceutical intervention took place. Results: A total of 106 DI were detected; 86% of DI found were related to drug’s pharmacokinetic properties, which were mostly metabolism related interactions (96.9%); the most commonly found associations were atazanavir with ritonavir, efavirenz with atorvastatin and efavirenz with gemfibrozil. The main clinical consequences associated with DI were ADR (49%). Conclusions: High prevalence of metabolism-related interactions was found and the antiretroviral drugs mostly associated with DI were found to be atazanavir, ritonavir y efavirenz. A high prevalence of ADR was found; however, they were mild or moderate.
topic adverse drug reactions
antiretroviral therapy
drug interactions
url http://jppres.com/jppres/pdf/vol5/jppres16.148_5.6.327.pdf
work_keys_str_mv AT patricioraraya druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
AT crissvzambra druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
AT yoselynmcastillo druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
AT pedropusedo druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
AT franciscolsalvador druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
AT franciscojgonzalez druginteractionsinhivpatientstreatedinahighcomplexityhospitalofantofagastacity
_version_ 1725990771662782464